GLSIGreenwich LifeSciencesGLSI info
$12.39info-1.04%24h
Global rank17856
Market cap$159.19M
Change 7d-6.21%
YTD Performance17.44%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Greenwich LifeSciences (GLSI) Stock Overview

    Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

    GLSI Stock Information

    Symbol
    GLSI
    Address
    Building 14Stafford, TX 77477United States
    Founded
    -
    Trading hours
    -
    Website
    https://greenwichlifesciences.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    832 819 3232

    Greenwich LifeSciences (GLSI) Price Chart

    -
    Value:-

    Greenwich LifeSciences Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $12.39
    N/A
    Market Cap
    $159.19M
    N/A
    Shares Outstanding
    12.85M
    N/A
    Employees
    3.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org